Table 1 Information on the 12 patients who underwent high-throughput sequencing.
From: MiRNA expression profiling and clinical implications in prostate cancer across various stages
Patient number | Age (years) | Prostate TMN staging |
|---|---|---|
WXH | 74 | BPH |
HQ | 79 | BPH |
CYC | 67 | BPH |
HLZ | 66 | T2N0M0 |
CAG | 66 | T2N0M0 |
LCY | 64 | T2N0M0 |
ZGA | 70 | T3bN1M0 |
PWJ | 73 | T3aN0M0 |
XW | 70 | T3bM0N0 |
QCL | 63 | T4N0M1 |
WJQ | 64 | T4N0M0 |
WWC | 63 | T4N0M1 |